Edition:
United States

Cosmo Pharmaceuticals NV (COPN.S)

COPN.S on Swiss Exchange

124.00CHF
11:31am EDT
Change (% chg)

CHF2.00 (+1.64%)
Prev Close
CHF122.00
Open
CHF122.40
Day's High
CHF124.90
Day's Low
CHF122.40
Volume
25,607
Avg. Vol
11,575
52-wk High
CHF151.00
52-wk Low
CHF103.60

Revenue & Earnings Per Share

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.75 32.14
P/E High - Last 5 Yrs. -- 41.76 46.82
P/E Low - Last 5 Yrs. -- 23.56 24.71
Beta -- 0.89 0.87
Price to Sales (TTM) 50.98 4.59 6.55
Price to Book (MRQ) -- 3.64 4.00
Price to Tangible Book (MRQ) 43.49 5.22 6.10
Price to Cash Flow (TTM) 290.92 20.18 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.82 1.68
Dividend Yield - 5 Year Avg -- 1.53 1.45
Dividend 5 Year Growth Rate -- -8.81 -5.91
Payout Ratio(TTM) 0.00 49.52 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 33.25 5.48 7.91
Sales (TTM) vs TTM 1 Yr. Ago 20.10 4.52 6.56
Sales - 5 Yr. Growth Rate 14.15 6.86 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago 61.61 19.36 26.63
EPS (TTM) vs TTM 1 Yr. Ago -12.72 -- --
EPS - 5 Yr. Growth Rate 32.16 6.47 7.65
Capital Spending - 5 Yr. Growth Rate 12.06 7.62 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.55 2.22 2.22
Current Ratio (MRQ) 1.60 2.97 2.99
LT Debt to Equity (MRQ) 3.75 8.83 11.31
Total Debt to Equity (MRQ) 6.02 11.15 14.15
Interest Coverage (TTM) 32.91 40.44 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 55.30 55.18 54.36
Gross Margin - 5 Yr. Avg. 54.63 53.20 53.16
EBITD Margin (TTM) 21.25 -- --
EBITD - 5 Yr. Avg 23.98 18.67 16.13
Operating Margin (TTM) 14.98 12.80 3.36
Operating Margin - 5 Yr. Avg. 15.98 14.30 11.28
Pre-Tax Margin (TTM) 13.91 13.31 3.79
Pre-Tax Margin - 5 Yr. Avg. 16.34 14.69 11.54
Net Profit Margin (TTM) 11.25 9.92 0.60
Net Profit Margin - 5 Yr. Avg. 12.48 10.95 7.83
Effective Tax Rate (TTM) 19.11 20.78 20.73
Effective Tax Rate - 5 Yr. Avg. 23.66 23.93 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 232,246 833,339,537 725,680,242
Net Income/Employee (TTM) 26,138 96,510,060 84,001,075
Receivable Turnover (TTM) 5.48 5.04 5.06
Inventory Turnover (TTM) 10.18 2.55 3.65
Asset Turnover (TTM) 0.39 0.84 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 4.42 10.12 9.83
Return on Assets - 5 Yr. Avg. 6.43 11.43 10.94
Return on Investment (TTM) 5.61 13.18 12.83
Return on Investment - 5 Yr. Avg. 8.22 14.72 14.05
Return on Equity (TTM) 6.12 15.14 14.95
Return on Equity - 5 Yr. Avg. 9.77 15.90 15.39
  1 Year 3 Year 5 Year
Sales % 20.10 13.53 14.15
EPS (TTM) % -10.80 204.08 32.16
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cosmo Pharmaceuticals NV

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 80
13 Week -- -- -- 74
26 Week -- -- -- 53
52 Week -- -- -- 47
YTD -- -- -- 46
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.